4.42
price up icon8.87%   0.36
after-market After Hours: 4.42
loading

Neuphoria Therapeutics Inc Stock (NEUP) Forecast

The Neuphoria Therapeutics Inc (NEUP) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.00, representing a -100.00% decrease from the current price of $4.42. The highest analyst price target is $0.00, and the lowest is $0.00.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NEUP Price Target
Average 0.00 (-100.00% Downside)
loading

Is Neuphoria Therapeutics Inc (NEUP) A Buy Now?

Oscillators
Name Value Action
RSI(14) 67.91 Neutral
STOCH(9,6) 59.26 Neutral
STOCHRSI(14) 100.00 Sell
MACD(12,26) 0.00775 Buy
ADX(14) 24.66 Neutral
William %R -4.00 Sell
CCI(14) 320.52 Buy
Buy: 2 Sell: 2 Neutral: 3
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
4.0665
Buy
4.1088
Buy
MA20
4.064
Buy
4.0781
Buy
MA50
4.0272
Buy
4.4273
Sell
MA100
6.3288
Sell
5.4174
Sell
MA200
7.1279
Sell
5.5906
Sell
Buy: 5 Sell: 5 Neutral: 0
Summary: Neutral
According to our latest analysis, NEUP could be considered a Neutral, with 17 technical analysis indicators signaling 7 Buy signals, 7 signaling Sell signals and 3 Neutral signals. This suggests that investors should exercise caution when entering new positions on NEUP, as the market is likely to remain volatile in the near term.
  1. RSI (Relative Strength Index): The RSI(14) value of 67.91 indicates that NEUP is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 59.26 indicates that NEUP is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that NEUP is oversold. This suggests that NEUP price is at or near the highest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 24.66 suggests that there may be some movement in price, but it lacks strength or conviction.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 320.52 indicates that NEUP is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.

Neuphoria Therapeutics Inc Stock (NEUP) Year by Year Forecast

$45.34
price down icon 0.15%
$27.48
price up icon 1.44%
$102.99
price up icon 1.81%
$107.95
price up icon 0.90%
$151.11
price up icon 0.39%
biotechnology ONC
$359.05
price up icon 1.18%
Cap:     |  Volume (24h):